Skip to search formSkip to main contentSkip to account menu

Ospemifene

Known as: Z-2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol, Deamino-hydroxytoremifene, 2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

FC-1271a
Ospemifene 60 MG Oral Tablet [Osphena]analogs & derivatives

Broader (1)

Tamoxifen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy
Abstract Objectives To determine whether assessment of all moderate-to-severe symptoms at baseline gives a more accurate… 
2014
2014
The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy
Abstract Objectives To explore clinically relevant differences in severity of vulvar and vaginal atrophy (VVA) in postmenopausal… 
2014
2014
Effects of Ospemifene on Breast Tissue Morphology and Proliferation: A Comparative Study Versus Other Selective Estrogen Receptor Modulators in Ovariectomized Rats
Abstract Ospemifene is a tissue-selective estrogen agonist/antagonist that was recently approved for the treatment of dyspareunia… 
Review
2014
Review
2014
Ospemifene for the treatment of dyspareunia in postmenopausal women.
Ospemifene is a third-generation selective estrogen receptor modulator (SERM), structurally closely related to toremifene… 
Review
2014
Review
2014
Ospemifene for the Treatment of Vulvovaginal Atrophy and Dyspareunia in Postmenopausal Women
Vulvovaginal atrophy (VVA) and dyspareunia are common problems experienced by postmenopausal women, although few seek treatment… 
Review
2013
Review
2013
Ospemifene: First Global Approval
Ospemifene (Osphena™) is an oral selective estrogen receptor modulator (SERM), with tissue-specific estrogenic agonist/antagonist… 
Review
2009
Review
2009
Ospemifene use in postmenopausal women
Background: Selective estrogen receptor modulators (SERMs) are structurally different compounds that interact with intracellular… 
2008
2008
Pharmacologic effects of ospemifene in rhesus macaques: a pilot study.
Ospemifene (Ophena) is a new selective oestrogen receptor modulator currently in phase III clinical development for treatment of… 
Review
2004
Review
2004
Ospemifene Hormos.
Hormos Medical is developing the selective estrogen receptor modulator ospemifene, for the potential treatment of postmenopausal… 
Review
2003
Review
2003
Novel therapies for osteoporosis
Osteoporosis remains a significant clinical problem despite effective therapies. Many patients cannot or will not take currently… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)